Global Prescription Drugs Market Growth 2020-2025
According to this study, over the next five years the Prescription Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prescription Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Prescription Drugs, covering the supply chain analysis, impact assessment to the Prescription Drugs market size growth rate in several scenarios, and the measures to be undertaken by Prescription Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Brand Drugs
Generic Drug
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Amgen
Roche
Johnson & Johnson
Merck & Co. (MSD)
Sanofi
Gilead Sciences
Novartis
GlaxoSmithKline (GSK)
AbbVie
Novo Nordisk
Takeda
Allergan
AstraZeneca
Teva
Eli Lilly
Takeda
Bayer
Bristol-Myers Squibb
Boehringer Ingelheim
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Prescription Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Prescription Drugs market by identifying its various subsegments.
Focuses on the key global Prescription Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prescription Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Prescription Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prescription Drugs Consumption 2015-2025
2.1.2 Prescription Drugs Consumption CAGR by Region
2.2 Prescription Drugs Segment by Type
2.2.1 Brand Drugs
2.2.2 Generic Drug
2.3 Prescription Drugs Consumption by Type
2.3.1 Global Prescription Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Prescription Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Prescription Drugs Sale Price by Type (2015-2020)
2.4 Prescription Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Prescription Drugs Consumption by Application
2.5.1 Global Prescription Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Prescription Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Prescription Drugs Sale Price by Type (2015-2020)
3 Global Prescription Drugs by Company
3.1 Global Prescription Drugs Sales Market Share by Company
3.1.1 Global Prescription Drugs Sales by Company (2018-2020)
3.1.2 Global Prescription Drugs Sales Market Share by Company (2018-2020)
3.2 Global Prescription Drugs Revenue Market Share by Company
3.2.1 Global Prescription Drugs Revenue by Company (2018-2020)
3.2.2 Global Prescription Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Prescription Drugs Sale Price by Company
3.4 Global Prescription Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Prescription Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Prescription Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Prescription Drugs by Regions
4.1 Prescription Drugs by Regions
4.2 Americas Prescription Drugs Consumption Growth
4.3 APAC Prescription Drugs Consumption Growth
4.4 Europe Prescription Drugs Consumption Growth
4.5 Middle East & Africa Prescription Drugs Consumption Growth
5 Americas
5.1 Americas Prescription Drugs Consumption by Countries
5.1.1 Americas Prescription Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Prescription Drugs Value by Countries (2015-2020)
5.2 Americas Prescription Drugs Consumption by Type
5.3 Americas Prescription Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Prescription Drugs Consumption by Regions
6.1.1 APAC Prescription Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Prescription Drugs Value by Regions (2015-2020)
6.2 APAC Prescription Drugs Consumption by Type
6.3 APAC Prescription Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Prescription Drugs by Countries
7.1.1 Europe Prescription Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Prescription Drugs Value by Countries (2015-2020)
7.2 Europe Prescription Drugs Consumption by Type
7.3 Europe Prescription Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Prescription Drugs by Countries
8.1.1 Middle East & Africa Prescription Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Prescription Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Prescription Drugs Consumption by Type
8.3 Middle East & Africa Prescription Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Prescription Drugs Distributors
10.3 Prescription Drugs Customer
11 Global Prescription Drugs Market Forecast
11.1 Global Prescription Drugs Consumption Forecast (2021-2025)
11.2 Global Prescription Drugs Forecast by Regions
11.2.1 Global Prescription Drugs Forecast by Regions (2021-2025)
11.2.2 Global Prescription Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Prescription Drugs Forecast by Type
11.8 Global Prescription Drugs Forecast by Application
12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Prescription Drugs Product Offered
12.1.3 Pfizer Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Amgen
12.2.1 Company Information
12.2.2 Prescription Drugs Product Offered
12.2.3 Amgen Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Amgen Latest Developments
12.3 Roche
12.3.1 Company Information
12.3.2 Prescription Drugs Product Offered
12.3.3 Roche Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Roche Latest Developments
12.4 Johnson & Johnson
12.4.1 Company Information
12.4.2 Prescription Drugs Product Offered
12.4.3 Johnson & Johnson Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Merck & Co. (MSD)
12.5.1 Company Information
12.5.2 Prescription Drugs Product Offered
12.5.3 Merck & Co. (MSD) Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Merck & Co. (MSD) Latest Developments
12.6 Sanofi
12.6.1 Company Information
12.6.2 Prescription Drugs Product Offered
12.6.3 Sanofi Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Sanofi Latest Developments
12.7 Gilead Sciences
12.7.1 Company Information
12.7.2 Prescription Drugs Product Offered
12.7.3 Gilead Sciences Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Gilead Sciences Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Prescription Drugs Product Offered
12.8.3 Novartis Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 GlaxoSmithKline (GSK)
12.9.1 Company Information
12.9.2 Prescription Drugs Product Offered
12.9.3 GlaxoSmithKline (GSK) Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 GlaxoSmithKline (GSK) Latest Developments
12.10 AbbVie
12.10.1 Company Information
12.10.2 Prescription Drugs Product Offered
12.10.3 AbbVie Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 AbbVie Latest Developments
12.11 Novo Nordisk
12.11.1 Company Information
12.11.2 Prescription Drugs Product Offered
12.11.3 Novo Nordisk Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Novo Nordisk Latest Developments
12.12 Takeda
12.12.1 Company Information
12.12.2 Prescription Drugs Product Offered
12.12.3 Takeda Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Takeda Latest Developments
12.13 Allergan
12.13.1 Company Information
12.13.2 Prescription Drugs Product Offered
12.13.3 Allergan Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Allergan Latest Developments
12.14 AstraZeneca
12.14.1 Company Information
12.14.2 Prescription Drugs Product Offered
12.14.3 AstraZeneca Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 AstraZeneca Latest Developments
12.15 Teva
12.15.1 Company Information
12.15.2 Prescription Drugs Product Offered
12.15.3 Teva Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Teva Latest Developments
12.16 Eli Lilly
12.16.1 Company Information
12.16.2 Prescription Drugs Product Offered
12.16.3 Eli Lilly Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Eli Lilly Latest Developments
12.17 Takeda
12.17.1 Company Information
12.17.2 Prescription Drugs Product Offered
12.17.3 Takeda Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Takeda Latest Developments
12.18 Bayer
12.18.1 Company Information
12.18.2 Prescription Drugs Product Offered
12.18.3 Bayer Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Bayer Latest Developments
12.19 Bristol-Myers Squibb
12.19.1 Company Information
12.19.2 Prescription Drugs Product Offered
12.19.3 Bristol-Myers Squibb Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Bristol-Myers Squibb Latest Developments
12.20 Boehringer Ingelheim
12.20.1 Company Information
12.20.2 Prescription Drugs Product Offered
12.20.3 Boehringer Ingelheim Prescription Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Boehringer Ingelheim Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Prescription Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Brand Drugs
Table 5. Major Players of Generic Drug
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Prescription Drugs Consumption Market Share by Type (2015-2020)
Table 8. Global Prescription Drugs Revenue by Type (2015-2020) ($ million)
Table 9. Global Prescription Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Prescription Drugs Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Prescription Drugs Consumption Market Share by Application (2015-2020)
Table 13. Global Prescription Drugs Value by Application (2015-2020)
Table 14. Global Prescription Drugs Value Market Share by Application (2015-2020)
Table 15. Global Prescription Drugs Sale Price by Application (2015-2020)
Table 16. Global Prescription Drugs Sales by Company (2017-2019) (K Units)
Table 17. Global Prescription Drugs Sales Market Share by Company (2017-2019)
Table 18. Global Prescription Drugs Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Prescription Drugs Revenue Market Share by Company (2017-2019)
Table 20. Global Prescription Drugs Sale Price by Company (2017-2019)
Table 21. Global Prescription Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Prescription Drugs Products Offered
Table 23. Prescription Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Prescription Drugs Consumption by Regions 2015-2020 (K Units)
Table 25. Global Prescription Drugs Consumption Market Share by Regions 2015-2020
Table 26. Global Prescription Drugs Value by Regions 2015-2020 ($ Millions)
Table 27. Global Prescription Drugs Value Market Share by Regions 2015-2020
Table 28. Americas Prescription Drugs Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Prescription Drugs Consumption Market Share by Countries (2015-2020)
Table 30. Americas Prescription Drugs Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Prescription Drugs Value Market Share by Countries (2015-2020)
Table 32. Americas Prescription Drugs Consumption by Type (2015-2020) (K Units)
Table 33. Americas Prescription Drugs Consumption Market Share by Type (2015-2020)
Table 34. Americas Prescription Drugs Consumption by Application (2015-2020) (K Units)
Table 35. Americas Prescription Drugs Consumption Market Share by Application (2015-2020)
Table 36. APAC Prescription Drugs Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Prescription Drugs Consumption Market Share by Regions (2015-2020)
Table 38. APAC Prescription Drugs Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Prescription Drugs Value Market Share by Regions (2015-2020)
Table 40. APAC Prescription Drugs Consumption by Type (2015-2020) (K Units)
Table 41. APAC Prescription Drugs Consumption Market Share by Type (2015-2020)
Table 42. APAC Prescription Drugs Consumption by Application (2015-2020) (K Units)
Table 43. APAC Prescription Drugs Consumption Market Share by Application (2015-2020)
Table 44. Europe Prescription Drugs Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Prescription Drugs Consumption Market Share by Countries (2015-2020)
Table 46. Europe Prescription Drugs Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Prescription Drugs Value Market Share by Countries (2015-2020)
Table 48. Europe Prescription Drugs Consumption by Type (2015-2020) (K Units)
Table 49. Europe Prescription Drugs Consumption Market Share by Type (2015-2020)
Table 50. Europe Prescription Drugs Consumption by Application (2015-2020) (K Units)
Table 51. Europe Prescription Drugs Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Prescription Drugs Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Prescription Drugs Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Prescription Drugs Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Prescription Drugs Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Prescription Drugs Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Prescription Drugs Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Prescription Drugs Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Prescription Drugs Consumption Market Share by Application (2015-2020)
Table 60. Prescription Drugs Distributors List
Table 61. Prescription Drugs Customer List
Table 62. Global Prescription Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Prescription Drugs Consumption Market Forecast by Regions
Table 64. Global Prescription Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Prescription Drugs Value Market Share Forecast by Regions
Table 66. Global Prescription Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Prescription Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Prescription Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Prescription Drugs Value Market Share Forecast by Type (2021-2025)
Table 70. Global Prescription Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Prescription Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Prescription Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Prescription Drugs Value Market Share Forecast by Application (2021-2025)
Table 74. Pfizer Product Offered
Table 75. Pfizer Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Pfizer Basic Information, Company Total Revenue (in $ million), Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Amgen Product Offered
Table 80. Amgen Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Amgen Main Business
Table 82. Amgen Latest Developments
Table 83. Amgen Basic Information, Company Total Revenue (in $ million), Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Roche Product Offered
Table 85. Roche Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Roche Main Business
Table 87. Roche Latest Developments
Table 88. Roche Basic Information, Company Total Revenue (in $ million), Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Product Offered
Table 90. Johnson & Johnson Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Johnson & Johnson Main Business
Table 92. Johnson & Johnson Latest Developments
Table 93. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck & Co. (MSD) Product Offered
Table 95. Merck & Co. (MSD) Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Merck & Co. (MSD) Main Business
Table 97. Merck & Co. (MSD) Latest Developments
Table 98. Merck & Co. (MSD) Basic Information, Company Total Revenue (in $ million), Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Product Offered
Table 100. Sanofi Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Sanofi Basic Information, Company Total Revenue (in $ million), Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Gilead Sciences Product Offered
Table 105. Gilead Sciences Basic Information, Company Total Revenue (in $ million), Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Gilead Sciences Main Business
Table 107. Gilead Sciences Latest Developments
Table 108. Gilead Sciences Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Novartis Product Offered
Table 110. Novartis Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Novartis Main Business
Table 112. Novartis Latest Developments
Table 113. Novartis Basic Information, Company Total Revenue (in $ million), Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline (GSK) Product Offered
Table 115. GlaxoSmithKline (GSK) Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. GlaxoSmithKline (GSK) Main Business
Table 117. GlaxoSmithKline (GSK) Latest Developments
Table 118. GlaxoSmithKline (GSK) Basic Information, Company Total Revenue (in $ million), Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. AbbVie Product Offered
Table 120. AbbVie Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. AbbVie Main Business
Table 122. AbbVie Latest Developments
Table 123. AbbVie Basic Information, Company Total Revenue (in $ million), Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Novo Nordisk Product Offered
Table 125. Novo Nordisk Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. Novo Nordisk Main Business
Table 127. Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Novo Nordisk Latest Developments
Table 129. Takeda Product Offered
Table 130. Takeda Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Takeda Main Business
Table 132. Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Takeda Latest Developments
Table 134. Allergan Product Offered
Table 135. Allergan Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. Allergan Main Business
Table 137. Allergan Latest Developments
Table 138. Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. AstraZeneca Product Offered
Table 140. AstraZeneca Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 141. AstraZeneca Main Business
Table 142. AstraZeneca Latest Developments
Table 143. AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Teva Product Offered
Table 145. Teva Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 146. Teva Main Business
Table 147. Teva Latest Developments
Table 148. Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Eli Lilly Product Offered
Table 150. Eli Lilly Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 151. Eli Lilly Main Business
Table 152. Eli Lilly Latest Developments
Table 153. Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Takeda Product Offered
Table 155. Takeda Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 156. Takeda Main Business
Table 157. Takeda Latest Developments
Table 158. Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Bayer Product Offered
Table 160. Bayer Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 161. Bayer Main Business
Table 162. Bayer Latest Developments
Table 163. Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. Bristol-Myers Squibb Product Offered
Table 165. Bristol-Myers Squibb Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 166. Bristol-Myers Squibb Main Business
Table 167. Bristol-Myers Squibb Latest Developments
Table 168. Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 169. Boehringer Ingelheim Product Offered
Table 170. Boehringer Ingelheim Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 171. Boehringer Ingelheim Main Business
Table 172. Boehringer Ingelheim Latest Developments
Table 173. Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Prescription Drugs
Figure 2. Prescription Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Prescription Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Prescription Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Brand Drugs
Figure 7. Product Picture of Generic Drug
Figure 8. Global Prescription Drugs Consumption Market Share by Type (2015-2020)
Figure 9. Global Prescription Drugs Value Market Share by Type (2015-2020)
Figure 10. Prescription Drugs Consumed in Hospital
Figure 11. Global Prescription Drugs Market: Hospital (2015-2020) (K Units)
Figure 12. Global Prescription Drugs Market: Hospital (2015-2020) ($ Millions)
Figure 13. Prescription Drugs Consumed in Clinic
Figure 14. Global Prescription Drugs Market: Clinic (2015-2020) (K Units)
Figure 15. Global Prescription Drugs Market: Clinic (2015-2020) ($ Millions)
Figure 16. Prescription Drugs Consumed in Other
Figure 17. Global Prescription Drugs Market: Other (2015-2020) (K Units)
Figure 18. Global Prescription Drugs Market: Other (2015-2020) ($ Millions)
Figure 19. Global Prescription Drugs Consumption Market Share by Application (2015-2020)
Figure 20. Global Prescription Drugs Value Market Share by Application (2015-2020)
Figure 21. Global Prescription Drugs Sales Market Share by Company in 2017
Figure 22. Global Prescription Drugs Sales Market Share by Company in 2019
Figure 23. Global Prescription Drugs Revenue Market Share by Company in 2017
Figure 24. Global Prescription Drugs Revenue Market Share by Company in 2019
Figure 25. Global Prescription Drugs Sale Price by Company in 2019
Figure 26. Global Prescription Drugs Consumption Market Share by Regions 2015-2020
Figure 27. Global Prescription Drugs Value Market Share by Regions 2015-2020
Figure 28. Americas Prescription Drugs Consumption 2015-2020 (K Units)
Figure 29. Americas Prescription Drugs Value 2015-2020 ($ Millions)
Figure 30. APAC Prescription Drugs Consumption 2015-2020 (K Units)
Figure 31. APAC Prescription Drugs Value 2015-2020 ($ Millions)
Figure 32. Europe Prescription Drugs Consumption 2015-2020 (K Units)
Figure 33. Europe Prescription Drugs Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Prescription Drugs Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Prescription Drugs Value 2015-2020 ($ Millions)
Figure 36. Americas Prescription Drugs Consumption Market Share by Countries in 2019
Figure 37. Americas Prescription Drugs Value Market Share by Countries in 2019
Figure 38. Americas Prescription Drugs Consumption Market Share by Type in 2019
Figure 39. Americas Prescription Drugs Consumption Market Share by Application in 2019
Figure 40. United States Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 41. United States Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Prescription Drugs Consumption Market Share by Countries in 2019
Figure 47. APAC Prescription Drugs Value Market Share by Regions in 2019
Figure 48. APAC Prescription Drugs Consumption Market Share by Type in 2019
Figure 49. APAC Prescription Drugs Consumption Market Share by Application in 2019
Figure 50. China Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 51. China Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 58. India Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 59. India Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Prescription Drugs Consumption Market Share by Countries in 2019
Figure 63. Europe Prescription Drugs Value Market Share by Countries in 2019
Figure 64. Europe Prescription Drugs Consumption Market Share by Type in 2019
Figure 65. Europe Prescription Drugs Consumption Market Share by Application in 2019
Figure 66. Germany Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. France Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 69. France Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. UK Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 71. UK Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Prescription Drugs Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Prescription Drugs Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Prescription Drugs Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Prescription Drugs Consumption Market Share by Application in 2019
Figure 80. Egypt Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Prescription Drugs Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Prescription Drugs Value Growth 2015-2020 ($ Millions)
Figure 90. Global Prescription Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Prescription Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Prescription Drugs Consumption 2021-2025 (K Units)
Figure 93. Americas Prescription Drugs Value 2021-2025 ($ Millions)
Figure 94. APAC Prescription Drugs Consumption 2021-2025 (K Units)
Figure 95. APAC Prescription Drugs Value 2021-2025 ($ Millions)
Figure 96. Europe Prescription Drugs Consumption 2021-2025 (K Units)
Figure 97. Europe Prescription Drugs Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Prescription Drugs Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Prescription Drugs Value 2021-2025 ($ Millions)
Figure 100. United States Prescription Drugs Consumption 2021-2025 (K Units)
Figure 101. United States Prescription Drugs Value 2021-2025 ($ Millions)
Figure 102. Canada Prescription Drugs Consumption 2021-2025 (K Units)
Figure 103. Canada Prescription Drugs Value 2021-2025 ($ Millions)
Figure 104. Mexico Prescription Drugs Consumption 2021-2025 (K Units)
Figure 105. Mexico Prescription Drugs Value 2021-2025 ($ Millions)
Figure 106. Brazil Prescription Drugs Consumption 2021-2025 (K Units)
Figure 107. Brazil Prescription Drugs Value 2021-2025 ($ Millions)
Figure 108. China Prescription Drugs Consumption 2021-2025 (K Units)
Figure 109. China Prescription Drugs Value 2021-2025 ($ Millions)
Figure 110. Japan Prescription Drugs Consumption 2021-2025 (K Units)
Figure 111. Japan Prescription Drugs Value 2021-2025 ($ Millions)
Figure 112. Korea Prescription Drugs Consumption 2021-2025 (K Units)
Figure 113. Korea Prescription Drugs Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Prescription Drugs Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Prescription Drugs Value 2021-2025 ($ Millions)
Figure 116. India Prescription Drugs Consumption 2021-2025 (K Units)
Figure 117. India Prescription Drugs Value 2021-2025 ($ Millions)
Figure 118. Australia Prescription Drugs Consumption 2021-2025 (K Units)
Figure 119. Australia Prescription Drugs Value 2021-2025 ($ Millions)
Figure 120. Germany Prescription Drugs Consumption 2021-2025 (K Units)
Figure 121. Germany Prescription Drugs Value 2021-2025 ($ Millions)
Figure 122. France Prescription Drugs Consumption 2021-2025 (K Units)
Figure 123. France Prescription Drugs Value 2021-2025 ($ Millions)
Figure 124. UK Prescription Drugs Consumption 2021-2025 (K Units)
Figure 125. UK Prescription Drugs Value 2021-2025 ($ Millions)
Figure 126. Italy Prescription Drugs Consumption 2021-2025 (K Units)
Figure 127. Italy Prescription Drugs Value 2021-2025 ($ Millions)
Figure 128. Russia Prescription Drugs Consumption 2021-2025 (K Units)
Figure 129. Russia Prescription Drugs Value 2021-2025 ($ Millions)
Figure 130. Spain Prescription Drugs Consumption 2021-2025 (K Units)
Figure 131. Spain Prescription Drugs Value 2021-2025 ($ Millions)
Figure 132. Egypt Prescription Drugs Consumption 2021-2025 (K Units)
Figure 133. Egypt Prescription Drugs Value 2021-2025 ($ Millions)
Figure 134. South Africa Prescription Drugs Consumption 2021-2025 (K Units)
Figure 135. South Africa Prescription Drugs Value 2021-2025 ($ Millions)
Figure 136. Israel Prescription Drugs Consumption 2021-2025 (K Units)
Figure 137. Israel Prescription Drugs Value 2021-2025 ($ Millions)
Figure 138. Turkey Prescription Drugs Consumption 2021-2025 (K Units)
Figure 139. Turkey Prescription Drugs Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Prescription Drugs Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Prescription Drugs Value 2021-2025 ($ Millions)
Figure 142. Pfizer Prescription Drugs Market Share (2018-2020)
Figure 143. Amgen Prescription Drugs Market Share (2018-2020)
Figure 144. Roche Prescription Drugs Market Share (2018-2020)
Figure 145. Johnson & Johnson Prescription Drugs Market Share (2018-2020)
Figure 146. Merck & Co. (MSD) Prescription Drugs Market Share (2018-2020)
Figure 147. Sanofi Prescription Drugs Market Share (2018-2020)
Figure 148. Gilead Sciences Prescription Drugs Market Share (2018-2020)
Figure 149. Novartis Prescription Drugs Market Share (2018-2020)
Figure 150. GlaxoSmithKline (GSK) Prescription Drugs Market Share (2018-2020)
Figure 151. AbbVie Prescription Drugs Market Share (2018-2020)
Figure 152. Novo Nordisk Prescription Drugs Market Share (2018-2020)
Figure 153. Takeda Prescription Drugs Market Share (2018-2020)
Figure 154. Allergan Prescription Drugs Market Share (2018-2020)
Figure 155. AstraZeneca Prescription Drugs Market Share (2018-2020)
Figure 156. Teva Prescription Drugs Market Share (2018-2020)
Figure 157. Eli Lilly Prescription Drugs Market Share (2018-2020)
Figure 158. Takeda Prescription Drugs Market Share (2018-2020)
Figure 159. Bayer Prescription Drugs Market Share (2018-2020)
Figure 160. Bristol-Myers Squibb Prescription Drugs Market Share (2018-2020)
Figure 161. Boehringer Ingelheim Prescription Drugs Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets